default author photo

Camille Bigenwald

Gustave Roussy - Hematology Department

Villejuif

France

SCHOLARLY PAPERS

3

DOWNLOADS

217

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Infectious Complications in Patients Treated with T-Cell Engager for Solid Tumours or Haematological Malignancies, a Descriptive Study from the REISAMIC Registry

Number of pages: 33 Posted: 12 Nov 2024
University of Paris-Saclay - Department of Hematology, Gustave Roussy, Gustave Roussy, Gustave Roussy, University of Paris-Saclay - Institut Pasteur, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Comité de Pathologies Thoraciques, Université Paris Saclay - Department of Children and Adolescents Oncology, Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Aix Marseille Université, Gustave Roussy, University of Paris-Saclay, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy - Drug Development Department (DITEP)
Downloads 114 (621,896)

Abstract:

Loading...

T-cell engager, infections, haematological malignancy, solid tumour

2.

Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and GNA3 Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study

Number of pages: 35 Posted: 14 Mar 2022
Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Translational Research Hematological Laboratory, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Medical Imaging Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Hematology Department, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), INSERM U1170, Université Paris-Saclay, Gustave Roussy, Gustave Roussy - Department of Medical Biology and Pathology, Gustave Roussy - Translational Research Hematological Laboratory and Gustave Roussy - Drug Development Department (DITEP)
Downloads 63 (933,592)

Abstract:

Loading...

Lymphoma large B-cell diffuse, Molecular sequencing, Prognosis biomarker, Genetic cluster analysis, Guanine nucleotide binding protein (G protein) alpha 13 human

3.

Fertility after CAR T-Cell Therapy, a Survey on Management and Outcomes from the Cellular Therapy and Immunobiology Working Party of the EBMT

Number of pages: 21 Posted: 11 Feb 2026
San Raffaele Institute, EMBT, EMBT, University of Paris-Saclay - Institut Gustave Roussy, Gustave Roussy - Hematology Department, Université Paris Cité, Université Paris Cité, Assistance Publique-Hopitaux de Paris (AP-HP) - Service d’Hematologie-Oncologie, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, University College London, University College London, St. James’s Hospital, University of Leipzig, University of Leipzig, University of Leipzig, University Hospitals Birmingham NHS Foundation Trust, University of Salamanca - Instituto de Investigación Biomédica de Salamanca - Institute for Biomedical Research of Salamanca, Technische Universität München (TUM), IRCCS Humanitas Research Hospital, IRCCS Humanitas Research Hospital, University of Seville - Hospital Universitario Virgen del Rocío, Hospital Clínic de Barcelona, University of Copenhagen - Copenhagen University Hospital, Charles University, University Hospitals Bristol - University Hospitals Bristol NHS Foundation Trust, University of Southampton - Southampton General Hospital, Tel Aviv Sourasky Medical Center, Hebrew University of Jerusalem - Hadassah Medical Center, University Hospital Essen, University Hospital of Schleswig-Holstein, National research Institute of Oncology, Warsaw, Université de Tours, EMBT, Hospital Universitario Puerta de Hierro, CHRU Nancy, Sorbonne University, Utrecht University - University Medical Center (Utrecht) and San Raffaele Institute
Downloads 40 (1,196,171)

Abstract:

Loading...

CAR T-Cells, Fertilíty Preservation, Pregnancies, Quality of Life